Commercial Implant Experience of a Helix‐Fixation Dual‐Chamber Leadless Pacemaker
Journal of Cardiovascular Electrophysiology · 2025-07 · 36 (7) · 1559-1566
DOI: 10.1111/jce.16688 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 09.05.2025. Verfasst von Cyrus A Hadadi und 11 weiteren Autor:innen. Beteiligte Einrichtung: MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, D.C., USA. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Cardiac Pacing, Artificial, Arrhythmias, Cardiac. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Introduction
The AVEIR DR pacemaker (Abbott) is a dual‐chamber leadless pacemaker (LP) system that includes right atrial and right ventricular helix‐fixation LPs (ALP, VLP), with atrioventricular synchrony maintained via wireless communication between the two devices. The initial, multi‐center commercial implant experience of the AVEIR DR dual‐chamber LP system has yet to be evaluated.
Methods
Patients indicated for dual‐chamber pacing after US commercial release were consecutively included. Implant procedural characteristics were evaluated, and electrical parameters were measured during pre‐fixation mapping, post‐fixation tether mode, after LP release, and before patient discharge. Any acute procedure‐ or device‐related complications within 30 days were noted.
Results
Patients were implanted with AVEIR DR per standard practice ( N = 175 at 8 centers; 72 ± 11 years; 60% male; 62% sinus node dysfunction, 37% AV block; 83% de novo implants). ALPs were implanted predominantly in the base of the right atrial appendage (82%), VLPs in the mid‐to‐apical right ventricular septum (94%). Pre‐fixation mapping allowed repositioning to be avoided in 95% of ALPs and VLPs. The total procedure duration was 64 ± 33 min, from initial incision to final suture, with a cumulative fluoroscopy duration of 13 ± 8 min. In both LPs, capture thresholds and sensed amplitudes improved significantly before patient discharge (ALP 1.2 ± 1.0 V, 2.1 ± 1.1 mV; VLP 0.8 ± 0.6 V, 9.5 ± 3.8 mV). At 30 days post‐implant, 99% of patients were complication‐free.
Conclusion
The initial commercial experience of the helix‐fixation, dual‐chamber LP system demonstrated safe and efficient implantation with clinically acceptable electrical metrics and minimal acute complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, D.C., USA.
- Health First Medical Group, Melbourne, Florida, USA.
- Arkansas Heart Hospital, Little Rock, Arkansas, USA.
- Huntington Hospital, Pasadena, California, USA.
- Libin Cardiovascular Institute, Calgary, Alberta, Canada.
- Department of Cardiology, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
ORCID-Profile: Zayd Eldadah, Nima Badie
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Hadadi, C. A., Lee, K. W., Lo, M., Rashtian, M., Exner, D. V., Mondésert, B., Thomaides, A., Alexander, N., Eldadah, Z., Badie, N., Ryu, K., & Nair, D. G. (2025). Commercial Implant Experience of a Helix‐Fixation Dual‐Chamber Leadless Pacemaker. Journal of Cardiovascular Electrophysiology, 36(7), 1559-1566. https://doi.org/10.1111/jce.16688
Vancouver
Hadadi CA, Lee KW, Lo M, Rashtian M, Exner DV, Mondésert B, et al. Commercial Implant Experience of a Helix‐Fixation Dual‐Chamber Leadless Pacemaker. Journal of Cardiovascular Electrophysiology. 2025;36(7):1559-1566. doi:10.1111/jce.16688
BibTeX
@article{Hadadi2025,
author = {Hadadi, Cyrus A and Lee, Ken W and Lo, Monica and Rashtian, Mayer and Exner, Derek V and Mondésert, Blandine and Thomaides, Athanasios and Alexander, Nebu and Eldadah, Zayd and Badie, Nima and Ryu, Kyungmoo and Nair, Devi G},
title = {Commercial Implant Experience of a Helix‐Fixation Dual‐Chamber Leadless Pacemaker},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
volume = {36},
number = {7},
pages = {1559--1566},
doi = {10.1111/jce.16688}
}
EUVIMED